This new report from Venture Planning Group provides analysis of ALT/SGPT testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals
- Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices
- Ambulatory Care Centers
- Cancer Clinics
- Surgery Centers List of Tables France: ALT/SGPT Test Volume and Diagnostics Sales Forecasts
By Market Segment, 2013-2018
Germany: ALT/SGPT Test Volume and Diagnostics Sales Forecasts
By Market Segment, 2013-2018
Italy: ALT/SGPT Test Volume and Diagnostics Sales Forecasts
By Market Segment, 2013-2018
Japan: ALT/SGPT Test Volume and Diagnostics Sales Forecasts
By Market Segment, 2013-2018
Spain: ALT/SGPT Test Volume and Diagnostics Sales Forecasts
By Market Segment, 2013-2018
UK: ALT/SGPT Test Volume and Diagnostics Sales Forecasts
By Market Segment, 2013-2018
USA: ALT/SGPT Test Volume and Diagnostics Sales Forecasts
By Market Segment, 2013-2018
|